TY  - GEN
AU  - Lalonde,R L
AU  - Kowalski,K G
AU  - Hutmacher,M M
AU  - Ewy,W
AU  - Nichols,D J
AU  - Milligan,P A
AU  - Corrigan,B W
AU  - Lockwood,P A
AU  - Marshall,S A
AU  - Benincosa,L J
AU  - Tensfeldt,T G
AU  - Parivar,K
AU  - Amantea,M
AU  - Glue,P
AU  - Koide,H
AU  - Miller,R
TI  - Model-based drug development
SN  - 0009-9236
PY  - 2007///0816
KW  - Alzheimer Disease
KW  - drug therapy
KW  - Amines
KW  - pharmacology
KW  - Analgesics
KW  - Animals
KW  - Anticholesteremic Agents
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Caproates
KW  - Cholesterol
KW  - blood
KW  - Clinical Trials as Topic
KW  - legislation & jurisprudence
KW  - Cognition
KW  - drug effects
KW  - Computer Simulation
KW  - Cyclohexanecarboxylic Acids
KW  - Dose-Response Relationship, Drug
KW  - Drug Approval
KW  - Drug Design
KW  - Gabapentin
KW  - Glycoproteins
KW  - Guidelines as Topic
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hypercholesterolemia
KW  - Immunologic Factors
KW  - Meta-Analysis as Topic
KW  - Models, Biological
KW  - Models, Statistical
KW  - Muscarinic Agonists
KW  - Neuralgia, Postherpetic
KW  - Neutrophil Infiltration
KW  - Oximes
KW  - Pharmacokinetics
KW  - Pharmacology
KW  - Reproducibility of Results
KW  - Research Design
KW  - Stroke
KW  - United States
KW  - United States Food and Drug Administration
KW  - gamma-Aminobutyric Acid
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1038/sj.clpt.6100235
ER  -